Work

Abstract 342: A hepatocyte growth factor antagonist engineered by disruption of heparan sulfate binding

Year: 2010

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am10-342

Authors: Fabiola Cecchi, Deborah Pajalunga, Daniel C. Rabe, Benedetta Peruzzi, Andrew C. Fowler, Davida K. Blackman, Nicholas MacDonald, Stephen J. Stahl, Andrew R. Byrd, Donald P. Bottaro

Institutions: National Institutes of Health, National Cancer Institute, University of Colorado Boulder, National Institute of Allergy and Infectious Diseases

Language: English

Topic: Liver physiology and pathology

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2015795555

Cites:

Cited by:

Related to: 10